Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Shao

Vascular Surgery Fort Wayne, IN Medical Doctor

NPI 1508196122 CMS profile 250125

1818 Carew St Ste 230, Ste 230, Fort Wayne, IN 46805

Open in the dashboard

General payments

$154,540

316 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$46,956 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Michael Shao of Fort Wayne, IN is reported in the CMS Open Payments database as having received $154,540 across 316 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $46,956 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,071 44
2024 General $12,426 32
2023 General $22,763 38
2022 General $36,742 72
2021 General $2,796 41
2020 General $28,813 50
2019 General $47,929 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Shao
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Michael Shao were reported at $3,071. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Michael Shao Vascular Surgery median Middle half National median
2019 $47,929 $796 $226–$2,363 $163
2020 $28,813 $348 $118–$1,110 $114
2021 $2,796 $471 $158–$1,421 $132
2022 $36,742 $725 $222–$2,183 $149
2023 $22,763 $836 $257–$2,440 $160
2024 $12,426 $909 $252–$2,619 $164
2025 $3,071 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $57,592 77 payments
  2. Biocompatibles, Inc. $47,039 13 payments
  3. Medtronic, Inc. $45,724 119 payments
  4. Baxter Healthcare $1,080 1 payment
  5. Janssen Pharmaceuticals, Inc $991 47 payments
  6. Tactile Systems Technology Inc $439 16 payments
  7. Medtronic Vascular, Inc. $250 2 payments
  8. Bard Peripheral Vascular, Inc. $224 6 payments
  9. Smith+Nephew, Inc. $223 15 payments
  10. W. L. Gore & Associates, Inc. $200 1 payment
  11. Other $778 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $89,124 30 payments
  2. Consulting Fee $22,568 6 payments
  3. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $22,500 6 payments
  4. Food and Beverage $10,720 215 payments
  5. Travel and Lodging $9,576 57 payments
  6. Education $53 2 payments
Products named General payments · program years 2019–2025
  1. VARITHENA Foam Sclerotherapy $47,039 13 payments
  2. Varithena Administration Pack $28,156 34 payments
  3. VARITHENA Foam Sclerotherapy $27,274 36 payments
  4. VENASEAL $24,976 77 payments
  5. ENDURANT IIS $10,792 23 payments
  6. ClosureFast $8,738 7 payments
  7. GENERAL THERAPIES $1,500 2 payments
  8. COSEAL $1,080 1 payment
  9. XARELTO $991 47 payments
  10. Abre $641 6 payments
  11. Other $4,428 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

111

Median for Vascular Surgery: 122

Drug cost

$9,243

Median for Vascular Surgery: $14,135

Branded share of claims

27%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Varenicline Tartrate Generic 25 $7,935
Cilostazol Generic 45 $803
Clopidogrel Clopidogrel Bisulfate Brand 30 $298
Triamcinolone Acetonide Generic 11 $207

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$111,116

Medicare's payments for the services billed

Medicare patients

239

Average age 75

Services billed

941

160 women, 79 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 38%
Diabetes 36%
Heart failure 26%
Chronic kidney disease 25%
Depression 21%
Atrial fibrillation 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

316 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record